Skip to main content

ADVERTISEMENT

Thrombolytic therapy

Case Report
04/19/2021

Erik E. Sanchez, MD1; Carlos A. Areán Martnez, MD2; Alfonso M. Ortiz, MD3

1Internal Medicine; 2Interventional Cardiology Department; 3Diagnostic Imaging Department, Hospital “General Dr. Miguel Silva”, Morelia, Michoacán, México

Erik E. Sanchez, MD1; Carlos A. Areán...
A 50-year-old man with a medical history of active smoking and diagnosed with type 2 diabetes mellitus was admitted to the ED complaining of sudden acute chest and left groin pain lasting 1 hour.
A 50-year-old man with a medical history of active smoking and diagnosed with type 2 diabetes mellitus was admitted to the ED complaining of sudden acute chest and left groin pain lasting 1 hour.
A 50-year-old man with a medical...
04/19/2021
Vascular Disease Management
Case Report
06/07/2017

Joseph Ibrahim1, MSII, Vatsal Bhatt1, MSIII, Pratik Patel2, MD
1Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey; 
2Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Joseph Ibrahim1, MSII, Vatsal Bhatt1,...
In this case report, we present a unique case of a saphenous vein graft (SVG) to obtuse marginal I (OM1) occlusion that was successfully treated with an alternative thrombolytic intervention followed by aspiration. 
In this case report, we present a unique case of a saphenous vein graft (SVG) to obtuse marginal I (OM1) occlusion that was successfully treated with an alternative thrombolytic intervention followed by aspiration. 
In this case report, we present...
06/07/2017
Cath Lab Digest
12/07/2015

Tod C. Engelhardt, MD, FACS, Vascular & Vein Institute, East Jefferson General Hospital, Metairie, Louisiana

Tod C. Engelhardt, MD, FACS, Vascular...
For a large majority of patients with acute intermediate-risk pulmonary embolism (PE), the usual standard of care of anticoagulation alone falls far short of saving lives and avoiding long-term sequelae, such as chronic thromboembolic...
For a large majority of patients with acute intermediate-risk pulmonary embolism (PE), the usual standard of care of anticoagulation alone falls far short of saving lives and avoiding long-term sequelae, such as chronic thromboembolic...
For a large majority of patients...
12/07/2015
Cath Lab Digest
Case Report
09/07/2011

Jon C. George, MD

Jon C. George, MD
Venous thromboembolic disease (VTE), including deep vein thrombosis and pulmonary embolus, is a frequent occurrence in clinical medicine. Current treatment options for VTE include long-term anticoagulation, thrombolytic therapy, surgical...
Venous thromboembolic disease (VTE), including deep vein thrombosis and pulmonary embolus, is a frequent occurrence in clinical medicine. Current treatment options for VTE include long-term anticoagulation, thrombolytic therapy, surgical...
Venous thromboembolic disease...
09/07/2011
Vascular Disease Management